Chairwoman Maloney Issues Statement on ONDCP Drug Control Policy Statement
Washington, D.C. (Apr. 1, 2021)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued this statement following release of the Office of National Drug Control Policy’s (ONDCP) Drug Control Policy Statement:
“I am pleased to see the Biden-Harris Administration’s ONDCP meet its first benchmark in the timely release of the required Drug Control Policy Statement, especially after the failures of the last administration.
“The seven stated priorities within ONDCP’s Policy Statement, including advancing racial equity and a reduction in youth substance use, forge paths to targeted evidence-based prevention efforts and desperately needed recovery services. It is my hope the Policy Statement’s emphasis on treatment and harm reduction services will stem the historic rise in drug overdose deaths recorded in the last year.
“Without a doubt, the coronavirus pandemic has exacerbated the drug abuse crisis in America, reflected in the loss of nearly 90,000 Americans due to drug overdose in the 12-month period ending August 2020—the largest recorded increase ever, and nearly 27% higher than the same period the previous year.
“I applaud the Biden-Harris Administration for taking this vital first step to build back better our country’s drug control policy, and look forward to partnering with ONDCP in the months to come to further bolster progress.”